Resultados de la búsqueda 111-120 of 2026 for fsa eligible items 2026

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligible patients will receive NACT with one ... Patients with BRCA mutations are not excluded from this trial and are allowed ... © 1998-2026 Fundación Mayo para ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligible patients will receive NACT with one ... Patients with BRCA mutations are not excluded from this trial and are allowed ... © 1998-2026 Fundación Mayo para ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligible patients will receive NACT with one ... Patients with BRCA mutations are not excluded from this trial and are allowed ... © 1998-2026 Fundación Mayo para ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligible patients will receive NACT with one ... Patients with BRCA mutations are not excluded from this trial and are allowed ... © 1998-2026 Fundación Mayo para ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...